| Title |
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
Diabetologia, April 2016
|
| DOI | 10.1007/s00125-016-3938-z |
| Pubmed ID | |
| Authors |
Lennart Tonneijck, Mark M. Smits, Marcel H. A. Muskiet, Trynke Hoekstra, Mark H. H. Kramer, A. H. Jan Danser, Michaela Diamant, Jaap A. Joles, Daniël H. van Raalte |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 2 | 40% |
| United States | 1 | 20% |
| Spain | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Scientists | 1 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 138 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 18% |
| Student > Ph. D. Student | 18 | 13% |
| Student > Bachelor | 14 | 10% |
| Researcher | 8 | 6% |
| Other | 6 | 4% |
| Other | 21 | 15% |
| Unknown | 47 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 32% |
| Nursing and Health Professions | 10 | 7% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Agricultural and Biological Sciences | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 13 | 9% |
| Unknown | 58 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2019.
All research outputs
#6,375,182
of 25,837,817 outputs
Outputs from Diabetologia
#2,620
of 5,411 outputs
Outputs of similar age
#83,999
of 316,695 outputs
Outputs of similar age from Diabetologia
#40
of 85 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 5,411 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,695 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.